Hypertension Explored in Long-term Postpartum Follow-up in Later Life
Hypertension Explored in Long-term Postpartum Follow-up in Later Life (HELPFUL)
University of Oxford
200 participants
Mar 23, 2023
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to understand more about why women who have had hypertensive pregnancies may be at increased risk of high blood pressure and why these women are often at increased risk of heart and blood vessel disease later in life.
Eligibility
Inclusion Criteria4
- Participant is willing and able to give informed consent for participation in the study
- Female who had a pregnancy 10 to 25 years prior
- Able (in the investigator's opinion) and willing to comply with all study requirements.
- Adequate understanding of verbal and written English
Exclusion Criteria6
- The participant may not enter the study if ANY of the following apply:
- Over 10 weeks pregnant during the course of the study
- Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status
- Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study
- For exclusion of MRI component only:
- • Unsuitable for MRI based on the responses to the MRI screening form. The participant may still be included in other parts of the study.
Interventions
Participants will attend one visit lasting approximately 3-4 hours on a single day or split over multiple visits to complete all measures. Participants will first be asked to provide written informed consent for the study. Participants' anthropometric measures (waist-to-hip ratio, height and weight, hip and waist circumference and left arm circumference and resting blood pressures will then be taken. After this, the participants will undergo cardiopulmonary exercise testing, followed by magnetic resonance imaging, echocardiography, retinal imaging and vascular imaging of the ear. The study visit will conclude with participants being provided with a wrist-worn physical activity monitor to wear for 7-9 days following the visit. These monitors will provide objective measures of physical activity while people go about their normal activities.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06187012